Page last updated: 2024-11-02

perphenazine and Parkinson Disease

perphenazine has been researched along with Parkinson Disease in 15 studies

Perphenazine: An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.
perphenazine : A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199014 (93.33)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stegmeier-Petroianu, A1
Petroianu, GA1
GOLDSCHMIDT, D1
MOTOSUGI, M1
SATO, K1
Sheppard, C1
Merlis, S1
Hale, MS1
Bellizzi, J1
Birkmayer, W1
Bruck, H1
Gerstenbrand, F1
Gnad, H1
Gründig, E1
Prosenz, P1
Turunen, S1
Achté, KA1
Pakkenberg, H1
Bottcher, J1
Patni, SK1
Dandiya, PC2
Brown, DM1
Hughes, BO1
Marsden, CD1
Meadows, JC1
Spicer, B1
Bhargava, LP1
Hader, M1
Salzberger, GJ1
Ekdawi, MY1
Fowke, R1

Trials

1 trial available for perphenazine and Parkinson Disease

ArticleYear
Some initial animal and human pharmacological studies with benapryzine (BRL 1288).
    British journal of pharmacology, 1973, Volume: 47, Issue:3

    Topics: Acetylcholine; Aged; Animals; Antiparkinson Agents; Benzilates; Clinical Trials as Topic; Dose-Respo

1973

Other Studies

14 other studies available for perphenazine and Parkinson Disease

ArticleYear
Hiccups and dopamine.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Nov-15, Volume: 65, Issue:22

    Topics: Amantadine; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Hiccup; H

2008
[Experiences and conclusions in regard to the use of hirepin. Part I].
    Ideggyogyaszati szemle, 1960, Volume: 13

    Topics: Chlorpromazine; Parkinson Disease; Perphenazine; Reserpine

1960
[A case report showing side effect of perphenazine in short term therapy].
    Nihon Jibiinkoka Gakkai kaiho, 1962, Volume: 65

    Topics: Humans; Parkinson Disease; Perphenazine

1962
Drug-induced extrapyramidal symptoms: their incidence and treatment.
    The American journal of psychiatry, 1967, Volume: 123, Issue:7

    Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp

1967
Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    The Journal of nervous and mental disease, 1980, Volume: 168, Issue:5

    Topics: Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Male; Midd

1980
[Experimental findings and new aspects in extrapyramidal diseases].
    Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete, 1966, Volume: 23, Issue:1

    Topics: 5-Hydroxytryptophan; Blood Pressure; Body Temperature Regulation; Chorea; Dihydroxyphenylalanine; Do

1966
[Comparative biochemical studies in organic parkinsonian syndromes and drug induced parkinsonian syndromes].
    Psychiatria et neurologia, 1966, Volume: 151, Issue:2

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Biochemical Phenomena; Biochemistry; Chlorpromazi

1966
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
    The Psychiatric quarterly, 1967, Volume: 41, Issue:2

    Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Ha

1967
Corpus striatum in paralysis agitans and in perphenazine-injected rats.
    Advances in neurology, 1974, Volume: 5

    Topics: Aged; Amphetamine; Amphetamines; Animals; Basal Ganglia; Caudate Nucleus; Chlorpromazine; Corpus Str

1974
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
    Japanese journal of pharmacology, 1972, Volume: 22, Issue:3

    Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibito

1972
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Archives internationales de pharmacodynamie et de therapie, 1968, Volume: 176, Issue:1

    Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine

1968
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
    Journal of the American Geriatrics Society, 1965, Volume: 13, Issue:10

    Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine;

1965
Control of agitation in institutionalized aged females.
    Diseases of the nervous system, 1966, Volume: 27, Issue:7

    Topics: Aged; Female; Humans; Hypertension; Mental Disorders; Middle Aged; Parkinson Disease; Perphenazine

1966
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    The British journal of psychiatry : the journal of mental science, 1966, Volume: 112, Issue:487

    Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic

1966